Orion Portfolio Solutions’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.6M Buy
36,222
+3,225
+10% +$148K 0.02% 823
2024
Q4
$1.19M Buy
32,997
+3,058
+10% +$107K 0.01% 954
2024
Q3
$959K Sell
29,939
-6,064
-17% -$227K 0.01% 1061
2024
Q2
$1.36M Buy
36,003
+7,125
+25% +$300K 0.01% 834
2024
Q1
$1.42M Buy
28,878
+7,124
+33% +$329K 0.02% 821
2023
Q4
$903K Sell
21,754
-6,823
-24% -$178K 0.01% 995
2023
Q3
$661K Sell
28,577
-614
-2% -$16.8K 0.01% 1090
2023
Q2
$765K Buy
29,191
+9,711
+50% +$255K 0.01% 1052
2023
Q1
$501K Buy
+19,480
New +$569K 0.01% 1140

Other funds holding SWTX

Orion Portfolio Solutions's SWTX Position: Q1 2025 in Review

Orion Portfolio Solutions increased its SpringWorks Therapeutics (SWTX) stake by 9.8% in Q1 2025, buying an estimated $148K and bringing the position to 36,222 shares worth $1.6M. The position accounts for 0.02% of the portfolio, ranked #823.

Orion Portfolio Solutions first reported a position in SWTX in Q1 2023 and has held it in 9 quarters since. 306 funds tracked by Wall St. Rank hold SWTX as of Q1 2025.

  • Orion Portfolio Solutions held 36,222 shares of SpringWorks Therapeutics worth $1.6M as of Q1 2025.
  • Orion Portfolio Solutions bought 3,225 SpringWorks Therapeutics shares in Q1 2025, an estimated $148K.
  • SpringWorks Therapeutics made up 0.02% of Orion Portfolio Solutions's portfolio in Q1 2025, its #823 holding.
  • Orion Portfolio Solutions first reported a position in SpringWorks Therapeutics in Q1 2023 and has held it in 9 quarters since.
  • 306 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.